In the News

Platinum Press welcomed Congressman Veasey to their Fort Worth facility, advocating for the Patients’ Right to Know Their Medication Act. They stressed the importance of printed medication information for patient safety and the economy. Veasey lauded their commitment, emphasizing the vital role of businesses like Platinum Press. Read More

The recent cyberattack on Change Healthcare illustrates the crucial need for printed medication information, as going digital could lead to dire consequences. The proposed FDA rule to move Patient Medication Information (PMI) online would increase vulnerability to cyber threats. Read More

The Pharmaceutical Printed Literature Association (PPLA) raises concerns about the FDA’s proposed rule to move Patient Medication Information (PMI) to a digital-only format, potentially harming rural patients’ access to essential health information due to limited broadband access. Read More

The Pharmaceutical Printed Literature Association (PPLA) advocates for the Patients’ Right to Know Their Medication Act (H.R. 1173), ensuring patients receive essential printed medication information. This is crucial for older, rural, and low-income individuals who may face challenges accessing digital information, ultimately improving health outcomes for Americans. Read More

Healthcare experts criticize the FDA’s proposal to digitize printed Patient Medication Information, citing concerns about accessibility, medication non-adherence, and strain on local pharmacies. Lawmakers have introduced the Patients’ Right to Know Their Medication Act (H.R. 1173) to address these issues. Read More

The Pharmaceutical Printed Literature Association (PPLA) emphasizes how the FDA’s proposed digital-only format for Patient Medication Information (PMI) would worsen health disparities. Many low-income Americans lack access to digital resources, risking medication non-adherence and adverse effects. The bipartisan Patients’ Right to Know Their Medication Act (H.R. 1173) aims to preserve printed PMI for patient safety. Read More

The Pharmaceutical Printed Literature Association (PPLA) warns about health risks of shifting Patient Medication Information (PMI) to digital format due to expiring broadband access program. Over 100,000 annual deaths result from medication non-adherence, posing risks for 42 million Americans without broadband. PPLA supports the Patients’ Right to Know Their Medication Act (H.R. 1173) to maintain… Read More

A study by MLPS reveals proposed changes in patient medication information delivery could cost the EU up to €3.5 billion annually. The bipartisan Patients’ Right to Know Their Medication Act aims to protect access to printed PMI and has 14 bipartisan cosponsors. The Pharmaceutical Printed Literature Association advocates for patient safety and accessibility. Read More

The Pharmaceutical Printed Literature Association (PPLA) is advocating for the Patients’ Right to Know Their Medication Act (H.R. 1173), with strong bipartisan Congressional support. The bill aims to ensure patients have access to printed Patient Medication Information (PMI) with FDA-approved content, resisting a proposed FDA rule to digitize PMI, which could hinder access for rural… Read More

The Pharmaceutical Printed Literature Association (PPLA) opposes the FDA’s rule lowering access to printed Patient Medication Information (PMI) due to its potential negative impact. The rule would shift PMI to digital format, raising concerns about access and cost. The PPLA advocates for the bipartisan Patients’ Right to Know Their Medication Act to standardize PMI based… Read More